Steris (STE) Total Debt Growth (3y) (2021 - 2026)
Steris (STE) Total Debt Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 24.63% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 4.89% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 11.72% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 0.11% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | -0.47% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.01% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -13.48% |
| 10 | Zimmer Biomet Holdings | 19.21 Bn | 18.80 Bn | 1.54 Bn | 9.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.48% |
| Mar 31, 2026 | -14.39% |
| Dec 31, 2025 | -14.73% |
| Sep 30, 2025 | -14.40% |
| Jun 30, 2025 | -14.05% |
| Mar 31, 2025 | -12.86% |
| Dec 31, 2024 | -13.15% |
| Sep 30, 2024 | -13.40% |
| Jun 30, 2024 | -10.81% |
| Mar 31, 2024 | 24.77% |
| Dec 31, 2023 | 24.54% |
| Sep 30, 2023 | 49.90% |
| Jun 30, 2023 | 40.36% |
| Mar 31, 2023 | 38.83% |
| Dec 31, 2022 | 39.12% |
| Sep 30, 2022 | 36.58% |
| Jun 30, 2022 | 35.31% |
| Mar 31, 2022 | 37.68% |
| Mar 31, 2021 | 7.84% |